PROCEPT BioRobotics Corporation
PRCT
$29.00
$0.070.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.26% | 37.22% | 50.07% | 55.71% | 59.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.26% | 37.22% | 50.07% | 55.71% | 59.36% |
| Cost of Revenue | 24.89% | 27.95% | 24.85% | 23.18% | 27.72% |
| Gross Profit | 31.87% | 43.13% | 68.80% | 82.62% | 86.89% |
| SG&A Expenses | 27.64% | 33.48% | 37.27% | 35.36% | 32.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.75% | 28.28% | 28.12% | 28.12% | 30.50% |
| Operating Income | -13.10% | -7.50% | 13.09% | 16.31% | 11.10% |
| Income Before Tax | -13.86% | -4.81% | 15.79% | 19.17% | 13.06% |
| Income Tax Expenses | -54.21% | -61.14% | -- | -- | -- |
| Earnings from Continuing Operations | -13.61% | -4.55% | 15.47% | 18.86% | 12.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.61% | -4.55% | 15.47% | 18.86% | 12.75% |
| EBIT | -13.10% | -7.50% | 13.09% | 16.31% | 11.10% |
| EBITDA | -12.65% | -6.66% | 14.77% | 18.03% | 12.82% |
| EPS Basic | -7.60% | 2.21% | 21.23% | 24.37% | 19.88% |
| Normalized Basic EPS | -7.82% | 1.95% | 21.52% | 24.65% | 20.15% |
| EPS Diluted | -7.60% | 2.21% | 21.23% | 24.37% | 19.88% |
| Normalized Diluted EPS | -7.82% | 1.95% | 21.52% | 24.65% | 20.15% |
| Average Basic Shares Outstanding | 5.35% | 6.56% | 7.16% | 7.28% | 8.88% |
| Average Diluted Shares Outstanding | 5.35% | 6.56% | 7.16% | 7.28% | 8.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |